Research partnerships · to be announced
Study type 1 diabetes, on a connected foundation.
GluCompass reads glucose, insulin, food, activity, sleep, stress and more as one connected signal. We're opening research partnerships with the groups who want to study type 1 diabetes with that breadth — on a research-ready, human-in-command foundation.
We're at the start: partnerships are in early discussion, and will be announced as they're confirmed.
Who we're opening this to
The groups who want to study type 1 properly.
If your work touches type 1 diabetes and you want richer, connected data than a single glucose line, we'd like to talk.
Hospitals & clinics
Endocrinology and diabetes units running studies alongside routine care.
Health funds & HMOs
Payers and integrated funds studying outcomes across a type 1 population.
Academic groups
Research teams investigating multi-signal drivers of glucose in type 1.
Care networks
Multi-site programs that need one connected view across clinics.
What GluCompass brings to a study
More signal, in one place.
Glucose read together with insulin, food, activity, sleep, stress and more — not one line in isolation.
The story of the days between appointments, continuously — where much of the signal actually lives.
Reads the CGMs, pumps and apps participants already use, on a human-in-command foundation.
Early, honest, and human-in-command.
The clinician and research surfaces are designed to begin in research settings — under ethics/IRB approval and their own consent and data-protection arrangements. Where a partner's protected health information is involved, that runs under the appropriate data-processing agreements.
We're at the beginning. Partnerships are in early discussion and will be named as they're confirmed. We make no efficacy or outcome claims until there is real, reviewed evidence to stand behind.
Let's talk
Have a study in mind?
Tell us what you'd want to learn about type 1 diabetes, and how your group works. We'll take it from there.